CHU Helora

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 32 trials

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Institut Jules Bordet1 trial
• UNICANCER1 trial

Running trials

• Recruiting

  Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

  NCT06606730· Phase 3· UNICANCER· Source

• Active, not recruiting

  Efficacy and safety of conventional neoadjuvant therapy versus total neoadjuvant therapy in older patients with locally advanced rectal cancer: a multicentre, open-label, randomised pragmatic clinical trial

  2023-506703-26-00· Phase 3· Institut Jules Bordet· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Triple-negative breast cancer1 recruiting